pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,580 catalysts · 6,271 phase readout · 2,303 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 32 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,271
  • 8k filing2,303
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07649655: EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Unresectable/Metastatic Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06549855: PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

Sponsor: Peking University People's Hospital. Phase: NA. Conditions: Endometrial Cancer, Endometrioid Carcinoma, Mismatch Repair Deficiency

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03534726: Edema and Fibrosis CMR Imaging in Cardiomyopathy

Sponsor: University of Pennsylvania. Phase: . Conditions: Cardiomyopathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT06778226: ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

Sponsor: University of Miami. Phase: . Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT06420726: Resistance Exercise and Creatine in Colorectal Cancer

Sponsor: University of South Carolina. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06514326: The Impact of Mechanisms of Action in Unguided Digital Mental Health Interventions

Sponsor: University of Haifa. Phase: NA. Conditions: DPT-STD, DPT-TP

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07641985: Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients

Sponsor: Maastricht University Medical Center. Phase: NA. Conditions: Breast Cancer, Breast Reconstruction, Breast Reconstruction After Mastectomy, Breast Cancer Radiation, Lipofilling

full page →ctgov ↗
›RECRUITINGphase readoutNCT07738185: The Impact of Post-Frenotomy Massages on Ankyloglossia Recurrence and Feeding Outcomes

Sponsor: Isaac Elijah. Phase: NA. Conditions: Ankyloglossia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06715943: Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment

Sponsor: Chengdu Suncadia Medicine Co., Ltd.. Phase: PHASE3. Conditions: Paroxysmal Nocturnal Hemoglobinuria

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06113315: A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07718035: Evaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compassion Fatigue

Sponsor: University of Malaya. Phase: NA. Conditions: Compassion Fatigue

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07596108: Calibre vs. COSMED

Sponsor: Duke University. Phase: NA. Conditions: Cardiorespiratory Fitness

full page →ctgov ↗
›COMPLETEDphase readoutNCT04617925: A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

Sponsor: Stichting European Myeloma Network. Phase: PHASE2. Conditions: AL Amyloidosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07407725: Clinical Outcome Assessment for AT & BCI

Sponsor: Shirley Ryan AbilityLab. Phase: NA. Conditions: Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06845176: Combining Motor Imagery and Tendon Vibration on the Effectiveness of Motor Imagery

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06052176: Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center. Phase: PHASE2. Conditions: Cirrhosis, Hepatic Encephalopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05005117: Laparoscopic Approach for Emergency Colon Resection

Sponsor: Joint Authority for Päijät-Häme Social and Health Care. Phase: NA. Conditions: Laparoscopic Surgery, Colorectal Cancer, Colorectal Disorders, Emergencies, Complication of Surgical Procedure, Long-term Effects of Cancer Treatment

full page →ctgov ↗
›RECRUITINGphase readoutNCT06909240: Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)

Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Deep Vein Thrombosis (DVT)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04670640: Mechanistic Interventions and Neuroscience of Dissociation

Sponsor: Emory University. Phase: NA. Conditions: Dissociation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07621289: Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe

Sponsor: University Hospital, Caen. Phase: . Conditions: Cancer, Anticancer Treatment, Cardiovascular Disease Risk Factor, Cardiovascular Diseases, Hematological Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT06239974: Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Chest Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07391774: Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07731997: IVUS Guidance in BTK Interventions

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital. Phase: NA. Conditions: Chronic Limb-Threatening Ischemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227597: A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Small Cell Lung Cancer Extensive Stage

full page →ctgov ↗
›TERMINATEDphase readoutNCT07668310: Effectiveness of PErcutaneous Ultrasound-guided Carpal Tunnel Release: a Non-inferiority Study With Surgery as Comparator

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07413510: Precision Nursing vs Conventional Care in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial

Sponsor: Jiangsu Cancer Institute & Hospital. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07381010: Learn About Caring for a Person Living With Dementia

Sponsor: Texas Christian University. Phase: PHASE1. Conditions: Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06890013: A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Acute Coronary Syndromes, Flow Mediated Dilation, Endothelial Function (FMD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07418060: Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Breast Cancer, Physiotherapy, Breast Reconstruction, Latissimus Dorsi Flap

full page →ctgov ↗
›COMPLETEDphase readoutNCT04261413: Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Sponsor: RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S.. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07735182: Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Sepsis, Acute Kidney Injury Due to Sepsis, Gastrointestinal Microbiome, Sepsis-Associated Liver Injury, Intensive Care Medicine

full page →ctgov ↗
›RECRUITINGphase readoutNCT07697482: Respiratory and Relaxation Training in Lower Extremity Lymphedema

Sponsor: Toros University. Phase: NA. Conditions: Lower Extremity Lymphedema

full page →ctgov ↗
›RECRUITINGphase readoutNCT07707323: Diagnostic Accuracy of Innovative Photo-Analysis Software in Resin Composite Shade Matching

Sponsor: Misr University for Science and Technology. Phase: NA. Conditions: Shade Matching

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07493980: Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: NSCLC Stage II

full page →ctgov ↗
›COMPLETEDphase readoutNCT06589323: Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in CABG (LEARNERS)

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Coronary Artery Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06687980: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

Sponsor: Sanofi. Phase: PHASE3. Conditions: Lichen Simplex Chronicus

full page →ctgov ↗
›COMPLETEDphase readoutNCT04253080: Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Cutaneous Melanoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05087680: An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South

Sponsor: Rhode Island Hospital. Phase: NA. Conditions: HIV Prevention

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07631780: SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure

Sponsor: Nurgul Ablakimova. Phase: NA. Conditions: Worsening Heart Failure, Congestion, Heart Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07596979: Ginger in the Modulation of Inflammatory Cytokines and Oxidative Stress in Patients With Coronary Artery Disease

Sponsor: Universidade Federal Fluminense. Phase: NA. Conditions: Coronary Artery Disease (CAD), Oxidative Stress, Inflammation

full page →ctgov ↗
›COMPLETEDphase readoutNCT05488379: Child Healthcare at MATER - Pediatric Study

Sponsor: Thomas Jefferson University. Phase: NA. Conditions: Opioid Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07450079: Characterising Sleep Disorders in Children With Tourette Syndrome

Sponsor: Steffi Baker. Phase: . Conditions: Tourette Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07716579: Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Brain Neoplasms, Endocrine System Diseases, Metabolic Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06917079: BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics). Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, NSCLC, PDAC - Pancreatic Ductal Adenocarcinoma, CRC (Colorectal Cancer), Metastatic Non-Small Lung Cell Cancer, Metastatic Colorectal Cancer (CRC), KRAS G12A, KRAS G12C, KRAS G12D, KRAS G12S, KRAS G12V, Metastatic Pancreatic Ductal Adenocarcinoma, Advanced Lung Carcinoma, Solid Tumor, Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07390162: The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of Oral Mucosal Pressure Injuries

Sponsor: Hacettepe University. Phase: NA. Conditions: Mucosal Wound, Mucosal Erosion, Mucosal Irritation, Endotracheal Intubation Fixation, Endotracheal Tube Position, Repositioning, Intensive Care Units (ICUs), Adult Patients, Pressure Ulcer Prevention

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07391696: Coffee Intake Biomarker Validation and Association With Respiratory Diseases

Sponsor: National University of Singapore. Phase: NA. Conditions: Coffee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07119996: Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE1. Conditions: Bladder (Urothelial, Transitional Cell) Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06898840: Establishing the Glycaemic Index of Fruit Drinks Using Different Measurement Methodologies

Sponsor: University of Bath. Phase: NA. Conditions: Glycaemic Index, Glycaemic Response Measurements

full page →ctgov ↗
›RECRUITINGphase readoutNCT06861868: Brain and Behavior Influences on Obesity Development From Infancy Through Childhood

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Obesity and Overweight

full page →ctgov ↗
›RECRUITINGphase readoutNCT07452991: ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. Phase: NA. Conditions: Pulmonary Embolism (PE)

full page →ctgov ↗
← prev
page 169 of 172
next →